Host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Steven E Nissen (Cleveland Clinic, Cleveland, OH, US) to discuss the results from the secondary analysis of the STRENGTH Trial. The study assessed the long-term outcomes statin residual risk with epanova in high cardiovascular risk patients with hypertriglyceridemia. Recorded remotely from Cleveland and Hamilton, 2021.
Editor: Mirjam Boros
Музыка
Фильмы
ТВ Шоу
Категории видео
